Brian Low Financial Group LLC bought a new position in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) in the 3rd quarter, Holdings Channel.com reports. The firm bought 6,664 shares of the exchange traded fund’s stock, valued at approximately $668,000.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. DHJJ Financial Advisors Ltd. purchased a new stake in SPDR S&P Biotech ETF during the 2nd quarter worth approximately $25,000. Capital A Wealth Management LLC acquired a new position in SPDR S&P Biotech ETF in the second quarter valued at approximately $26,000. Johnson Financial Group Inc. bought a new position in SPDR S&P Biotech ETF during the 2nd quarter worth $31,000. Twin Peaks Wealth Advisors LLC bought a new position in shares of SPDR S&P Biotech ETF during the second quarter worth about $32,000. Finally, AlphaCore Capital LLC increased its stake in shares of SPDR S&P Biotech ETF by 6,650.0% in the second quarter. AlphaCore Capital LLC now owns 540 shares of the exchange traded fund’s stock valued at $45,000 after purchasing an additional 532 shares during the period.
SPDR S&P Biotech ETF Price Performance
Shares of SPDR S&P Biotech ETF stock opened at $124.98 on Friday. SPDR S&P Biotech ETF has a 1-year low of $66.66 and a 1-year high of $126.50. The business’s fifty day moving average price is $117.08 and its two-hundred day moving average price is $100.07. The company has a market capitalization of $7.59 billion, a P/E ratio of 11.47 and a beta of 0.93.
SPDR S&P Biotech ETF Company Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Further Reading
- Five stocks we like better than SPDR S&P Biotech ETF
- Do not delete, read immediately
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- Can Any Expenses Be Deducted From Capital Gains Tax?
- Do you know what Amazon is planning for January 1?
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
